2015 Vaccines Process Development & Commercialization Workshop

June 23-25, 2015 • MIT, Cambridge, MA

Massachusetts Institute of Technology in collaboration with University College London is announcing its 2015 Vaccines Bioprocess Development & Commercialization Workshop.

This three day workshop will explore the critical issues at the various stages of vaccine development. International experts with over 10 years’ experience in their field will lead delegates in developing their understanding in the research, operational and regulatory challenges of the vaccine market. In addition to expert lectures and excellent networking opportunities with your peers, one case study will be conducted during the workshop about manufacturing at-risk with real examples from the influenza manufacturing process.


June 23 Keynote David C. Kaslow, PATH Speakers Barry Buckland, UCL John Aunins, SERES Derek O'Hagan, GSK Charles L. Cooney, MIT Katey Owen, B&MGF	June 24 Speakers Geoffrey Hodge, GEHC Life Sciences Alain Pralong, GSK Stephen A. Kolodziej, Pfizer, Inc. Indresh Srivastava, Protein Sciences Stacy L. Springs, MIT Martin Wisher, BioReliance René Labatut, sanofi pasteur Dave Clark, AstraZeneca	June 25 Speakers Tarit Mukhopadhyay, UCL J. Christopher Love, MIT Darrell Irvine , MIT Dan Barouch, Harvard Robin Robinson, BARDA

This workshop is suitable for:

Scientists new to the vaccines sector (recent graduates / research scientists).
Scientists and technical managers who wish to broaden their knowledge in various vaccine technologies and platforms, exploring the interplay between process choices and regulation.
Project Managers, funders and policy-makers wanting to gain an understanding in vaccines.